Is Evaxion Biotech A Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: EVAX) stock is to Strong Buy EVAX stock.
Out of 1 analyst, 1 (100%) are recommending EVAX as a Strong Buy, 0 (0%) are recommending EVAX as a Buy, 0 (0%) are recommending EVAX as a Hold, 0 (0%) are recommending EVAX as a Sell, and 0 (0%) are recommending EVAX as a Strong Sell.
What is EVAX's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: EVAX) forecast ROE is -680.31%, which is considered weak.
What is EVAX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year EVAX price target, the average EVAX price target is $7.00, with the highest EVAX stock price forecast at $7.00 and the lowest EVAX stock price forecast at $7.00.
The Wall Street analyst predicted that Evaxion Biotech A's share price could reach $7.00 by Mar 31, 2024. The average Evaxion Biotech A stock price prediction forecasts a potential upside of 438.46% from the current EVAX share price of $1.30.
What is EVAX's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: EVAX) forecast ROA is -256.46%, which is lower than the forecast US Biotechnology industry average of 11.82%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.